online ISSN 2415-3176
print ISSN 1609-6371
logoExperimental and Clinical Physiology and Biochemistry
🇬🇧 EN 🇺🇦 UA
Up
J. 2026, 106(2): 5–11

Clinical medicine

The Hemoglobin-to-Creatinine Ratio in Patients with Chronic Forms of Coronary Artery Disease and Arterial Hypertension

O. M. RADCHENKO¹, A. L. FILIPIUK¹, L. V. SIASIA¹, O. V. BASHKIRTSEV2

Received: 12-06-2026

Accepted: 23-09-2026

Published: 28-09-2026

Abstract

Currently, the clinical significance of the hemoglobin-to-creatinine (Hb/ Cr) ratio in patients with chronic forms of coronary artery disease (CAD) and arterial hypertension (AH) remains undetermined. Furthermore, its potential utility in the outpatient management of these individuals has not been fully explored, highlighting the relevance and necessity of this study.

Aim: To evaluate the hemoglobin-to-creatinine ratio in patients with chronic coronary artery disease and arterial hypertension, and to analyze its clinical correlations.


Materials and Methods. In compliance with the Declaration of Helsinki and following informed consent (Bioethics Committee Approval No. 2, Danylo Halytsky Lviv National Medical University, dated February 21, 2022), 53 outpatient men (mean age 57.4 ± 1.3 years) with chronic CAD and AH were examined. In addition to standard protocol assessments, fibrin monomers, D-dimer, and platelet aggregation activity (PAA) were measured. The de Ritis ratio and the hepatic steatosis index were calculated as markers of liver steatosis. Statistical analysis was performed using mathematical methods, with data presented as mean ± standard error (M ± m). The significance level was set at p < 0.05.


Results. The mean Hb/Cr ratio for the entire cohort was 1.53 ± 0.05. A decrease in this ratio was identified as an unfavorable sign, being accompanied by a progression in the functional class of chronic heart failure (HF), increased platelet aggregation, elevated fasting blood glucose, and left ventricular dilation associated with a reduced ejection fraction (all p < 0.05). Significantly lower values of the Hb/Cr ratio were observed in patients with uncontrolled arterial hypertension, higher heart failure functional classes, reduced ejection fraction, left ventricular dilation, as well as elevated erythrocyte sedimentation rate (ESR) and increased platelet aggregation activity.


Conclusion. The hemoglobin-to-creatinine ratio in patients with chronic coronary artery disease and arterial hypertension was 1.53 ± 0.05. A reduction in this ratio serves as an unfavorable clinical indicator.

Keywords: hemoglobin-to-creatinine ratio, coronary artery disease, arterial hypertension, heart failure, ejection fraction

Full text: PDF (Ukr)

References
  1. Zhang XR, Zhong WF, Liu RY, Huang JL, Fu JX, Gao J, et al. Improved prediction and risk stratification of major adverse cardiovascular events using an explainable machine learning approach combining plasma biomarkers and traditional risk factors. Cardiovasc Diabetol. 2025;24(1):153. doi.org/10.1186/s12933-025-02711-x
  2. Li J, Wei X. Baseline and changes in cardiometabolic index and incident cardiovascular disease in two prospective cohorts. Am J Prev Cardiol. 2025;23:101046. doi.org/10.1016/j.ajpc.2025.101046
  3. Demir M, Kahraman F, Sen T, Astarcioglu MA. The relationship of the hemoglobin to serum creatinine ratio with long-term mortality in patients with acute coronary syndrome: A retrospective study Medicine (Baltimore). 2023;102(41):e35636.doi.org/10.1097/MD.0000000000035636
  4. Spadafora L, Cacciatore S, Galli M, Collet C, Betti M, Sarto G, et al. Hemoglobin-to-Creatinine Ratio Predicts One-Year Adverse Clinical Outcomes in ST-Elevation Myocardial Infarction: Retrospective and Propensity Score Matched Analysis. J Clin Med. 2025;14(8):2756.doi.org/10.3390/jcm14082756
  5. Kang B, Zhang C, Li J, Chen L. Association between hemoglobin-to-creatinine ratio and all-cause mortality in patients with coronary artery disease. Egypt Heart J. 2025;77(1):109.doi.org/10.1186/s43044-025-00707-2
  6. Ji W, Chen Y, Zhou H, Huang W, Xu S. Prognostic value of hemoglobin to serum creatinine ratio in ST-elevation myocardial infarction: a secondary analysis based on a cohort study.BMC Cardiovasc Disord. 2025;25(1):394.doi.org/10.1186/s12872-025-04856-9
  7. Azizi Kia H, Mousavi A, Shojaei S, Shaker F, Salabat D, Bahri RA, et al. Predictive potential of pre-procedural cardiac and inflammatory biomarkers regarding mortality following transcatheter aortic valve implantation: A systematic review and meta-analysis. Heart Lung. 2025; 69:229–240.doi.org/10.1016/j.hrtlng.2024.10.011
  8. Radchenko OM, Komarytsia OI, Siasia LV, Struzh IuI. Hepatic steatosis index (HSI): diagnostic value in patients with stable angina pectoris. Experimental and Clinical Physiology and Biochemistry. 2025;3(105):32–37.doi.org/10.25040/ecpb2025.03.032
  9. Fu J, He A, Wang L, Li X, Yu J, Zheng R. Interpretable machine learning model for predicting delirium in patients with sepsis: a study based on the MIMIC data. BMC Infect Dis. 2025;25(1):585. doi.org/10.1186/s12879-025-10982-8
  10. Gergi M, Wilkinson K, Sparks A, Roetker NS, Al-Samkari H, Smith NL, et al. Anticoagulation and other risk factors for clinically relevant bleeding after medical hospitalization: the Medical Inpatient Thrombosis and Hemostasis Study. J Thromb Haemost. 2025;23(7):2122–2132.doi.org/10.1016/j.jtha.2025.02.044
  11. Marcon L, Della Rocca DG, Vetta G, Nakasone K, Sorgente A, de Asmundis C, et al. Hemolysis Biomarkers After Pulmonary Vein Isolation via a Balloon-In-Basket PFA Catheter. J Cardiovasc Electrophysiol. 2025;36(4):879–882. doi.org/10.1111/jce.16608
  12. Liu Y, Wang P, Wang M, Chen Y, Kasyanju SM, Yang Y, et al. Development and External Validation of a Machine Learning-Based Model for Predicting Heart Failure Risk in Type 2 Diabetes. Diabetes Metab Syndr Obes. 2025;18:4177–4191.doi.org/10.2147/DMSO.S558687
  13. Engin A. The Definition and Prevalence of Obesity and Metabolic Syndrome: Correlative Clinical Evaluation Based on Phenotypes. Adv Exp Med Biol. 2024;1460:1–25.doi.org/10.1007/978- 3-031-63657-8_1
  14. Lu Y, Ge J, Zhu L, Wang L, Wu J, Dong F, et al. Cardiometabolic-Kidney Indices and Machine Learning Model for Predicting All-Cause Mortality in Patients with Cardiovascuar-Kidney-Metabolic Syndrome: A Longitudinal Cohort Study. Am J Nephrol. 2025:1–15.doi.org/10.1159/000549578
  15. Engin A. The Definition and Prevalence of Obesity and Metabolic Syndrome: Correlative Clinical Evaluation Based on Phenotypes. Adv Exp Med Biol. 2024;1460:1–25.doi.org/10.1007/978-3-031-63657-8_1
  16. Lu Y, Ge J, Zhu L, Wang L, Wu J, Dong F, et al. Cardiometabolic-Kidney Indices and Machine Learning Model for Predicting All-Cause Mortality in Patients with Cardiovascular-Kidney-Metabolic Syndrome: A Longitudinal Cohort Study. Am J Nephrol. 2025:1–15. doi.org/10.1159/000549578


Bibliographic databases in which journal is registered:

copernicus.jpg Infobaseindex Google SCholar ICMJE Citefactor Research Bible Ebsco Med journal links Academickeys Українські наукові журнали  publons  CrossRef  Open Ukrainian Citation Index (OUCI)

    LNMUSVITНаціональна бібліотека України імені В. І. ВернадськогоУкраїнське Фізіологічне Товариство ім. П.Г. Костюка

© 2026 Experimental and Clinical Physiology and Biochemistry

Ліцензія Creative Commons Твір "Experimental and Clinical Physiology and Biochemistry Journal", створений Experimental and Clinical Physiology and Biochemistry Journal ліцензовано за ліцензією Creative Commons Із Зазначенням Авторства - Некомерційна - Поширення На Тих Самих Умовах 4.0 Міжнародна.
Засновано на творі з http://ecpb.org.ua/. Права, що виходять за рамки цієї ліцензії доступні за адресою http://ecpb.org.ua/editorial/



Програмування - Roman.im | QR-Code Generator